Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Omeros Corporation

Clinical trials sponsored by Omeros Corporation, explained in plain language.

Not yet finished but already full! 1 Completed 1 Terminated 3

New drug tested for rare blood disorder when standard treatment fails

Disease control Completed

This study tested a new drug called OMS906 for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease. It specifically looked at patients who weren't getting good results from their current standard treatment, ravulizumab. Researchers gave 12 participants two…

Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC